1-8 of 8
Ji-Suk Chang
Close
Sort by
Journal Articles

Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis

Anna M. Eiring, Paolo Neviani, Ramasamy Santhanam, Joshua J. Oaks, Ji Suk Chang, Mario Notari, William Willis, Carlo Gambacorti-Passerini, Stefano Volinia, Guido Marcucci, Michael A. Caligiuri, Gustavo W. Leone, Danilo Perrotti
Journal: Blood
Blood (2008) 111 (2): 816–828.
https://doi.org/10.1182/blood-2007-05-090472
Published: 2008
Journal Articles

Requirement of the E2F3 Transcription Factor for BCR/ABL Leukemogenesis.

Anna M. Eiring, BS, Paolo Neviani, D.Sci., Ramasamy Santhanam, Ph.D., Joshua J. Oaks, B.S., Ji Suk Chang, Ph.D., Carlo Gambacorti-Passerini, MD, Stefano Volinia, MD, Guido Marcucci, MD, Michael A. Caligiuri, MD, Gustavo W. Leone, Ph.D., Danilo Perrotti, MD, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 33.
https://doi.org/10.1182/blood.V110.11.33.33
Published: 2007
Journal Articles

CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer–binding protein alpha

Steffen Koschmieder, Francesco D'Alò, Hanna Radomska, Christine Schöneich, Ji Suk Chang, Marina Konopleva, Susumu Kobayashi, Elena Levantini, Nanjoo Suh, Annalisa Di Ruscio, Maria Teresa Voso, Julie C. Watt, Ramasamy Santhanam, Bülent Sargin, Hagop Kantarjian, Michael Andreeff, Michael B. Sporn, Danilo Perrotti, Wolfgang E. Berdel, Carsten Müller-Tidow, Hubert Serve, Daniel G. Tenen
Journal: Blood
Blood (2007) 110 (10): 3695–3705.
https://doi.org/10.1182/blood-2006-11-058941
Published: 2007
Includes: Supplemental data
Journal Articles

High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2–dependent suppression of C/EBPα-driven myeloid differentiation

Ji Suk Chang, Ramasamy Santhanam, Rossana Trotta, Paolo Neviani, Anna M. Eiring, Edward Briercheck, Mattia Ronchetti, Denis C. Roy, Bruno Calabretta, Michael A. Caligiuri, Danilo Perrotti
Journal: Blood
Blood (2007) 110 (3): 994–1003.
https://doi.org/10.1182/blood-2007-03-078303
Published: 2007
Journal Articles

Molecular and Pharmacologic Suppression of MAPK Activity Rescues Differentiation of BCR/ABL + Myeloid Progenitors by Releasing C/EBPa from the Inhibitory Effect of hnRNP E2.

Ji-Suk Chang, PhD, Ramasamy Santhanam, Ph.D, Edward Briercheck, B.S., Anna Eiring, B.S., Rossana Trotta, Ph.D, Mario Notari, D.Sci, Denis-Claude Roy, M.D., Michael A. Caligiuri, M.D., Danilo Perrotti, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2240.
https://doi.org/10.1182/blood.V108.11.2240.2240
Published: 2006
Journal Articles

A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation

Mario Notari, Paolo Neviani, Ramasamy Santhanam, Bradley W. Blaser, Ji-Suk Chang, Annamaria Galietta, Anne E. Willis, Denis C. Roy, Michael A. Caligiuri, Guido Marcucci, Danilo Perrotti
Journal: Blood
Blood (2006) 107 (6): 2507–2516.
https://doi.org/10.1182/blood-2005-09-3732
Published: 2006
Journal Articles

ReSETting PP2A Tumor Suppressor Activity Overcomes BCR/ABL Leukemogenic Potential in Blast Crisis CML.

Paolo Neviani, MS, Ramasamy Santhanam, Ph.D, Rossana Trotta, Ph.D, Mario Notari, MS, Bradley W. Blaser, BS, Ji-Suk Chang, Ph.D, Shujun Liu, Ph.D, Hsiaoyin Mao, MS, Joshua J. Oaks, BS, Denis C. Roy, MD, Mauro Valtieri, MD, Rebecca Bruner-Klisovic, MD, Michael A. Caligiuri, MD, Clara D. Bloomfield, MD, Guido Marcucci, MD, Danilo Perrotti, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1992.
https://doi.org/10.1182/blood.V106.11.1992.1992
Published: 2005
Journal Articles

BCR/ABL Post-Translationally Enhances hnRNP E2 Expression and Translation-Inhibitory Function through the Activation of ERK1/2 Mitogen-Activated Protein Kinases.

Ji-Suk Chang, PhD, Mario Notari, MS, Guido Marcucci, MD, Danilo Perrotti, MD, Ph.D
Journal: Blood
Blood (2005) 106 (11): 4376.
https://doi.org/10.1182/blood.V106.11.4376.4376
Published: 2005